vimarsana.com

Latest Breaking News On - Idhika paul - Page 6 : vimarsana.com

Shakib Khan making a comeback in Tollywood?

Dhallywood superstar Shakib Khan is all set to make a grand comeback to Tollywood after a break of five years. Known for his performance in joint productions like "Shikari", "Nabab", "Chalbaaz", "Naqab" and "Bhaijan Elo Re," Shakib's return has already created a buzz in the industry.

Priyotoma sells tickets worth Tk 25 crore by the end of third week

Shakib Khan starrer “Priyotoma”, directed by Himel Ashraf, has collected Tk 25 crores in ticket sales at the end of this week. The news was confirmed by its production company Versatile Media, to The Daily Star. After earning Tk 10 crore 30 lakhs and Tk 8 crore 55 lakhs respectively in the first and second week of release, the movie has so far sold tickets worth Tk 5 crore 75

A resurgence of playback songs

During the golden era of Bangladeshi cinemas, music was one of the key factors for a film to attract the audience towards theatres. In between bidding goodbye to the 35mm camera, and welcoming high-fidelity digital cameras in filmmaking, the music has been neglected for many years. As the film industry was suffering from a huge loss, it also hampered the film songs as well.

Priyotoma earns BDT 10 crore in a week, Shurongo second at BDT 2 5 crore

Eid releases this year have been a breath of fresh air for the industry, from small screen regulars debuting on the big screen to reviving cinema halls, Dhallywood has been turning a new leaf. Similarly, among Eid releases this Eid-ul-Azha, " Priyotoma" has amassed the largest earnings, with "Shurongo" following closely behind.

Eid films still going strong

Moreover, shows for Bubly and Nirab Hossain featurette "Casino" have been decreased by 15 halls. It was released in 16 halls across the country. The director of the film informed the media that it might get more halls in its third week. He also added that the film is in the talks for an international release as well.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.